Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
554.00Prev. Close
555.00Volume
22,732Total traded value
1.26 CrUpper Circuit
666.00Lower Circuit
444.00Fundamentals
| Market Cap | ₹1,109Cr |
| ROE | 12.26% |
| P/E Ratio(TTM) | 12.85 |
| EPS(TTM) | 43.11 |
| P/B Ratio | 1.65 |
| Dividend Yield | 0.33% |
| Industry P/E | 35.60 |
| Book Value | 335.34 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals is a dynamic pharmaceutical manufacturer specializing in a wide range of therapeutic molecules and providing affordable and innovative branded generic medicines. The company's core philosophy lies in its unwavering commitment to "Healthcare for All", focusing on delivering high-quality pharmaceutical products at affordable prices. Its strategic domestic expansion has been highly successful, achieving a market presence that covers over 80% of India.;
| Parent Organisation | Lincoln Pharmaceuticals Ltd |
| Managing Director | Mr. Mahendrabhai Patel |
| NSE Symbol | LINCOLN |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.38 | ||
| Gland Pharma | NA (0.00%) | 43.24 | ||
| Ajanta Pharma | NA (0.00%) | 34.20 | ||
| Eris Lifesciences | NA (0.00%) | 57.73 |